INSM – Insmed Incorporated
Insmed IncorporatedINSM
$72.51Name : Insmed Incorporated
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $12,972,257,280.00
EPSttm : -5.55
Insmed Incorporated
$72.51
0.33%$0.24Float Short %
8.84
Margin Of Safety %
Put/Call OI Ratio
0.77
EPS Next Q Diff
0.01
EPS Last/This Y
-0.02
EPS This/Next Y
1.16
Price
72.46
Target Price
89.53
Analyst Recom
1.06
Performance Q
-5.4
Relative Volume
1
Beta
1.11
Ticker: INSM
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | INSM | 69.36 | 0.92 | 0.15 | 85490 |
| 2024-12-20 | INSM | 70.44 | 0.91 | 0.01 | 85484 |
| 2024-12-23 | INSM | 70.54 | 0.85 | 3.20 | 66485 |
| 2024-12-24 | INSM | 70.53 | 0.86 | 0.59 | 67087 |
| 2024-12-26 | INSM | 70.72 | 0.85 | 0.45 | 67887 |
| 2024-12-27 | INSM | 69.62 | 0.85 | 1.39 | 68241 |
| 2024-12-30 | INSM | 68.85 | 0.85 | 0.05 | 68505 |
| 2024-12-31 | INSM | 69.07 | 0.85 | 0.11 | 68718 |
| 2025-01-02 | INSM | 69.96 | 0.84 | 0.85 | 69284 |
| 2025-01-03 | INSM | 69.81 | 0.85 | 0.54 | 69879 |
| 2025-01-06 | INSM | 66.62 | 0.86 | 0.13 | 70396 |
| 2025-01-07 | INSM | 66.1 | 0.81 | 0.29 | 73926 |
| 2025-01-08 | INSM | 65.75 | 0.81 | 0.83 | 73981 |
| 2025-01-09 | INSM | 65.72 | 0.81 | 0.80 | 73981 |
| 2025-01-10 | INSM | 65.31 | 0.82 | 0.13 | 74556 |
| 2025-01-13 | INSM | 68.96 | 0.82 | 0.28 | 74967 |
| 2025-01-14 | INSM | 68.3 | 0.80 | 0.20 | 76262 |
| 2025-01-15 | INSM | 70.07 | 0.80 | 0.04 | 76163 |
| 2025-01-16 | INSM | 72.77 | 0.80 | 0.01 | 76366 |
| 2025-01-17 | INSM | 72.49 | 0.77 | 0.23 | 78295 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | INSM | 69.40 | 7.4 | 147.7 | -5.36 |
| 2024-12-20 | INSM | 70.48 | 7.4 | 131.6 | -5.36 |
| 2024-12-23 | INSM | 70.59 | 7.4 | 140.5 | -5.36 |
| 2024-12-24 | INSM | 70.53 | 7.4 | 142.4 | -5.36 |
| 2024-12-26 | INSM | 70.67 | 7.4 | 140.5 | -5.36 |
| 2024-12-27 | INSM | 69.63 | 7.4 | 151.6 | -5.36 |
| 2024-12-30 | INSM | 68.90 | 7.4 | 148.6 | -5.36 |
| 2024-12-31 | INSM | 69.04 | 7.4 | 140.2 | -5.36 |
| 2025-01-02 | INSM | 69.98 | 7.4 | 132.8 | -5.36 |
| 2025-01-03 | INSM | 69.81 | 7.4 | 143.2 | -5.36 |
| 2025-01-06 | INSM | 66.64 | 7.4 | 172.4 | -5.36 |
| 2025-01-07 | INSM | 66.10 | 7.4 | 147.0 | -5.36 |
| 2025-01-08 | INSM | 65.72 | 7.4 | 145.8 | -5.36 |
| 2025-01-09 | INSM | 65.72 | 7.4 | 141.8 | -5.36 |
| 2025-01-10 | INSM | 65.26 | 7.4 | 146.5 | -5.36 |
| 2025-01-13 | INSM | 68.96 | 7.4 | 104.0 | -5.36 |
| 2025-01-14 | INSM | 68.24 | 7.4 | 148.5 | -5.36 |
| 2025-01-15 | INSM | 70.20 | 7.4 | 123.3 | -5.36 |
| 2025-01-16 | INSM | 72.74 | 7.4 | 117.9 | -5.36 |
| 2025-01-17 | INSM | 72.46 | 7.4 | 144.5 | -5.36 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | INSM | -8.10 | 8.51 | 7.23 |
| 2024-12-20 | INSM | -8.60 | 8.51 | 7.23 |
| 2024-12-23 | INSM | -8.49 | 8.61 | 7.23 |
| 2024-12-24 | INSM | -8.49 | 8.61 | 7.23 |
| 2024-12-26 | INSM | -8.61 | 8.61 | 7.45 |
| 2024-12-27 | INSM | -8.60 | 8.61 | 7.45 |
| 2024-12-30 | INSM | -8.72 | 8.50 | 7.45 |
| 2024-12-31 | INSM | -8.72 | 8.50 | 7.45 |
| 2025-01-02 | INSM | -8.58 | 8.50 | 7.45 |
| 2025-01-03 | INSM | -8.60 | 8.50 | 7.45 |
| 2025-01-06 | INSM | -9.11 | 8.64 | 7.45 |
| 2025-01-07 | INSM | -9.11 | 8.64 | 7.45 |
| 2025-01-08 | INSM | -9.10 | 8.64 | 7.45 |
| 2025-01-09 | INSM | -9.10 | 8.64 | 7.45 |
| 2025-01-10 | INSM | -9.10 | 8.64 | 7.45 |
| 2025-01-13 | INSM | -10.37 | 8.64 | 8.84 |
| 2025-01-14 | INSM | -10.37 | 8.64 | 8.84 |
| 2025-01-15 | INSM | -10.37 | 8.64 | 8.84 |
| 2025-01-16 | INSM | -10.37 | 8.64 | 8.84 |
| 2025-01-17 | INSM | -11.15 | 8.64 | 8.84 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.27
Avg. EPS Est. Current Quarter
-1.19
Avg. EPS Est. Next Quarter
-1.26
Insider Transactions
-11.15
Institutional Transactions
8.64
Beta
1.11
Average Sales Estimate Current Quarter
96
Average Sales Estimate Next Quarter
86
Fair Value
Quality Score
32
Growth Score
52
Sentiment Score
95
Actual DrawDown %
10
Max Drawdown 5-Year %
-63.3
Target Price
89.53
P/E
Forward P/E
PEG
P/S
37.82
P/B
26.83
P/Free Cash Flow
EPS
-5.56
Average EPS Est. Cur. Y
-5.36
EPS Next Y. (Est.)
-4.19
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-252.01
Relative Volume
1
Return on Equity vs Sector %
-197.9
Return on Equity vs Industry %
-185.3
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.06
EBIT Estimation
144.5
Insmed IncorporatedSector: Healthcare
Industry: Biotechnology
Employees: 912
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.
stock quote shares INSM – Insmed Incorporated Stock Price stock today
news today INSM – Insmed Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch INSM – Insmed Incorporated yahoo finance google finance
stock history INSM – Insmed Incorporated invest stock market
stock prices INSM premarket after hours
ticker INSM fair value insiders trading